Separate FDA submissions report mean small-bowel capsule review-time reductions of 88. 6% with ProScan-assisted reading and 24. 7% with a recently cleared comparator AI-assisted workflow.

PLANO, Texas, Oct. 11, 2026 /PRNewswire/ -- AnX Robotica today highlighted the documented results of clinical performance of NaviCam(R) ProScan(TM), its AI-assisted capsule endoscopy reading technology, following a recent U.S. Food and Drug Administration clearance of another AI-assisted capsule endoscopy platform.

In its September 25, 2026, 510(k) clearance (K254230), the FDA identifies NaviCam ProScan (DEN230027) as the primary predicate device.